EBSA Events
14th Annual Conference of the European Biosafety Association |
 |
| Estoril/Portugal |
|---|
| Workshops: 13 April 2011 Conference: 14 - 15 April 2011 |
5th Annual Conference of the European Biosafety Association, 2002
“National and Global Disease Outbreaks / Living with Bioterrorism”
Programme, Thursday, 21 March 2002 National and Global Disease Outbreaks
Chair: Prof. Dr. Franz X. Heinz, Institute of Virology, University of Vienna The Control of Foot and Mouth Disease Virus Outbreak in the Netherlands: The Role of Hygiene Bio-terrorism: Micro-organisms and Toxins as Weapons and Evaluation of Risk Dr. Robert Hawley Ph.D.,
Global Outbreak Alert and Response WHO's role in the fight against bio-terrrorism Mr. Arnold Herer, Vice President of IBA Technology Group, Belgium
12.30 – 12.45
EBSA Honorary Membership Biological Materials, Main Auditorium Transport of Biological Materials, Auditorium II
Chair Person: Mr. David J. Cocker, Dr. Nicoletta Previsani, CEN / ISO Standardisation Programme for Packaging of Infectious Substances Mr. Maxence Wittebolle, Shipping: Training Responsibilities in Clinical Trials Dr. Frank Verbeeck,
14.15 – 15.00
Concurrent Session IIb Pathogens Update, Main Auditorium
Chair Person: Mr. Martin Jones, HIV Emergence, Spread and Biosafety Aspects Dr. Remi Van Den Broeck The Polio Eradication Programme Dr. David Wood, Smallpox: Eradication, Virus Stocks and Bio-terrorism Prof. Dr. Riccardo Wittek,
16.40 - 17.10
Horizon Scanning: Outlook for 2002-2003,Arbovirus and Viral Haemorrhagic Fever an Overview
Dr. Hervé Zeller,
EBSA Annual General Meeting EBSA Members Only, Main Auditorium Evening Programme Vienna by night: EBSA Annual Reception and Dinner
Chair Person: Mr. Martin Jones, Dr. John Newbold, Mr. Alan Kelly, Group Safety in Biotechnology - EBSA's Partner in Biotech Safety Issues Prof. Dr. Otto Doblhoff, Dr. Arnaud Tarantola Chair Person: Prof. Dr. Helmut Bachmayer, Novartis Dr. Peter Schroeer Dr. Helmut Gaugitsch Dr. Ursula Jenal, Dr. Frank Verbeeck,
07.30 - 08.30
Registration
08.30 - 08.45
Welcome by EBSA President
Dr. Frank Verbeeck, Bristol-Myers Squibb, Belgium
08.45 – 12.30
Session I:
Living with Bio-terrorism
08.45 – 09.30
Dr. A. Dekker, Head Laboratory Vesicular Diseases, ID Lelystad Institute for Animal Science and Health, The Netherlands
09.30 – 10.00
The Foot and Mouth Disease Epidemic in the UK 2001
10.00 - 10.30
Break / Exhibition
10.30 - 11.10
CBSP, Chief, Safety and Radiation Protection, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, USA
11.10 - 11.40
Dr. Cathy Roth, Global Alert and Response Team, Dept of Surveillance and Response, Communicable Disease Cluster, WHO Geneva
11.40 - 12.15
Bio-terrorism – The Role of Irradiation as a Counter-measure to Bio-terrorism
12.15 - 12.30
Panel Discussion
12.45 - 14.15
Lunch / Exhibition
14.15 – 17.20
Concurrent Session IIb
15.00 – 17.00
Concurrent Session IIa
15.00 – 17.00
Concurrent Session IIa Transport of Biological Materials, Auditorium II
MDCPartners Healthcare Consultants, Belgium
15.00 - 15.30
Future Directions: WHO Policy on Transport Biosafety
Department of Communicable Disease Surveillance and Response, WHO, Geneva
15.30 - 16.00
Break / Exhibition
16.00 - 16.30
Belgian Packaging Institute, Brussels
16.30 - 17.00
Bristol-Myers Squibb, Belgium
Pfizer, La Jolla, California, USA
14.15 – 15.00
Medical Director Medisearch Int., Belgium
15.00 - 15.30
Vaccines and Biologicals Department, WHO, Geneva
15.30 - 16.00
Break / Exhibition
16.00 - 16.40
Institute for Animal Biology, Lausanne, Switzerland
National Reference Centre for Arbovirus and Viral Haemorrhagic Fever, Institute Pasteur Lyon, France
17.10 - 17.20
Discussion
17.30 - 18.30
19.15
Sponsored by Novartis International, Basle, Switzerland
Departure: 19.15 hrs, Lobby Kaiser Franz Joseph DeraghotelFriday, 22 March 2002
08.30 – 10.10
Session III Topics in Biosafety
Pfizer, La Jolla, California, USA
08.30 - 08.50
Microbiological Safety Cabinets – UK Perspective
Health and Safety Executive, UK
08.50 - 09.10
Biohazard Courses for Maintenance Staff
School of Biomedical Sciences, University of Leeds, UK
09.10- 09.30
The European Federation Biotechnology Task
Institute for Applied Microbiology, Vienna
09.30 - 10.10
Epidemiological Trends in Accidental Blood Exposure in European Countries
GERES, Paris (Study Group on Risks of Blood Exposure)
10.10 – 11.00
Break
11.00 – 12.30
Session IV Regulatory Update
11.00 - 11.30
Reuse of Single Use Medical Devices - Risk and Regulations
European Commission CEN
11.30 – 12.00
Deliberate Release of GMOs / Directive 2001/18/EC, Replacing Directive 90/220/EEC
Federal Environment Agency, Austria
12.00 – 12.30
The Joint European Enforcement Groups on the Contained Use of GMOs
Beratung Sicherheit, Switzerland
12.30
Closure - EBSA President:
Bristol-Myers Squibb, Belgium